Categories AlphaGraphs, Earnings, Retail

American Outdoor Brands (AOBC) beats Q2 targets, stock surges

Smith & Wesson gunmaker American Outdoor Brands (Nasdaq: AOBC) reported second-quarter earnings results. For the three-month period, the gunmaker’s adjusted EPS jumped 82% to $0.20 and sales grew 9% year-over-year to $161.7 million. Earnings and revenue surpassed both consensus and the company’s estimates. AOBC shares jumped more than 10% in the after-market session.

American Outdoor Brands Q2 2019 earnings infograph

For the quarter ending January 31, 2019, AOBC expects non-GAAP EPS to be in the range of 9 cents to 13 cents, GAAP EPS to be in the range of 1 cent to 5 cents, and revenue to be in the range of $155 million to $165 million.

For the fiscal year ending April 31, 2019, the company lifted its earnings and revenue outlook. Currently, non-GAAP EPS is targeted to be in the range of $0.69 to $0.73 versus the prior estimate of $0.62 to $0.66 and GAAP EPS is predicted to be in the range of $0.38 to $0.42 compared with the prior estimate of $0.32 to $0.36. Now, the company expects FY19 revenue to come in the range of $625 million to $635 million versus the prior expectation of $620 million to $630 million.

“We are pleased with our second quarter operational and financial results, which reflect year-over-year increases in revenue and profitability in both our Outdoor Products & Accessories segment and our Firearms segment,” said CEO James Debney.

Outdoor Products & Accessories segment generated approximately one-third of the company’s revenue in the second quarter with sales growth in Hunting & Shooting product categories, as well as our Cutlery & Tool product categories.

Revenue growth in the Firearms segment reflected the success of ‘bundle’ promotions booked earlier in the year and shipped in the second quarter.

American Outdoor Brands stock rallies on Q1 earnings beat

AOBC made significant progress in the quarter on the completion of its new Logistics & Customer Services facility in Missouri. The company remains on track to begin ramping initial operations of this 632,000 square foot, state-of-the-art facility in the near future.

In the Annual Meeting of Stockholders held on September 25, 2018, stockholders approved a proposal that the company issue a “gun safety” report. This proposal won by a margin of 52.16% to 47.84% of votes cast. Earlier, the leadership had recommended voting against the proposal saying that monitoring requested is unrealistic, not feasible, and would not prevent misuse of guns.

AOBC shares ended Thursday’s trading session up 3.30% at $12.21. The stock had dropped 17% in the past 3 months period and 14% in the past 52 weeks period.

 

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

 

Most Popular

Biogen (BIIB) stock research summary | Q3 2021

Neurological and neurodegenerative diseases affect a vast segment of the population worldwide and there is a significant demand for treatments for these conditions. Biogen (BIIB) has a strong portfolio of

Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), a market leader in generic drugs, reported lower revenues for the third quarter of 2021, citing a slowdown in North American sales. Meanwhile, earnings

Goldman Sachs (GS) stock research summary | Q3 2021

Goldman Sachs (GS) exceeded analysts’ expectations, as investment banking revenue surged nearly 90%. Goldman market research report covers key aspects about the firm including company profile, financial highlights and key

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top